# FDA 483 - Golden Shrimp Seafood Joint Stock Company - December 12, 2023

Source: https://www.keypedia.com/records/483/golden-shrimp-seafood-joint-stock-company/5a892303-a1cf-40b9-8649-5cd1448f32f5

> FDA 483 for Golden Shrimp Seafood Joint Stock Company on December 12, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Golden Shrimp Seafood Joint Stock Company
- Inspection Date: 2023-12-12
- Product Type: other
- Office Name: Office of Biological Products Operations - Division I
- Summary: An FDA inspection of Golden Shrimp Seafood Joint Stock Company in Tuy Hoa, Vietnam, revealed deficiencies in their HACCP plan, specifically regarding histamine testing procedures. The firm's sampling methods for histamine were found to be inadequate, failing to focus on areas where histamine is more likely to be detected. These issues are significant, as the firm has a history of consumer complaints related to scombrotoxin poisoning and product recalls due to elevated histamine levels in their frozen yellowfin tuna.

## Related Documents

- [WARNING_LETTER - 2023-12-12](https://www.keypedia.com/records/warning_letter/golden-shrimp-seafood-joint-stock-company/5bedae12-da3a-467e-9310-ebe1605c4f2d)

## Related Officers

- [investigator](https://www.keypedia.com/people/rashonda-n-rucker/68c5db63-be23-4aaa-89c4-2e692193321e)

Company: https://www.keypedia.com/companies/golden-shrimp-seafood-joint-stock-company/21f26293-8d81-4414-89d5-67085f3eed59

Office: https://www.keypedia.com/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1